- Home
- ZNTL vs FINS Comparison
ZNTL vs FINS Comparison
Compare ZNTL & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- FINS
- Stock Information
- Founded
- ZNTL 2014
- FINS 2019
- Country
- ZNTL United States
- FINS United States
- Employees
- ZNTL N/A
- FINS N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- FINS Finance/Investors Services
- Sector
- ZNTL Health Care
- FINS Finance
- Exchange
- ZNTL Nasdaq
- FINS Nasdaq
- Market Cap
- ZNTL 105.8M
- FINS 447.8M
- IPO Year
- ZNTL 2020
- FINS N/A
- Fundamental
- Price
- ZNTL $1.52
- FINS $13.17
- Analyst Decision
- ZNTL Buy
- FINS
- Analyst Count
- ZNTL 6
- FINS 0
- Target Price
- ZNTL $6.53
- FINS N/A
- AVG Volume (30 Days)
- ZNTL 729.8K
- FINS 78.0K
- Earning Date
- ZNTL 11-11-2025
- FINS 01-01-0001
- Dividend Yield
- ZNTL N/A
- FINS 9.97%
- EPS Growth
- ZNTL N/A
- FINS N/A
- EPS
- ZNTL N/A
- FINS N/A
- Revenue
- ZNTL $26,865,000.00
- FINS N/A
- Revenue This Year
- ZNTL N/A
- FINS N/A
- Revenue Next Year
- ZNTL N/A
- FINS N/A
- P/E Ratio
- ZNTL N/A
- FINS N/A
- Revenue Growth
- ZNTL N/A
- FINS N/A
- 52 Week Low
- ZNTL $1.01
- FINS $11.61
- 52 Week High
- ZNTL $4.46
- FINS $12.57
- Technical
- Relative Strength Index (RSI)
- ZNTL 46.28
- FINS 44.99
- Support Level
- ZNTL $1.40
- FINS $13.20
- Resistance Level
- ZNTL $2.02
- FINS $13.55
- Average True Range (ATR)
- ZNTL 0.11
- FINS 0.13
- MACD
- ZNTL -0.04
- FINS -0.02
- Stochastic Oscillator
- ZNTL 26.19
- FINS 9.52
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.